...
首页> 外文期刊>Journal of Pharmacy and Bioallied Sciences >Antihyperlipidemic effect of Trichilia connaroides in hypercholesterolemic rats and its possible mechanism
【24h】

Antihyperlipidemic effect of Trichilia connaroides in hypercholesterolemic rats and its possible mechanism

机译:凤眼虫对高胆固醇血症大鼠的降血脂作用及其可能机制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives:The primary objective of this study was to investigate the antihyperlipidemic effect of the chloroform (CETC) and methanol (METC) extracts of leaves of Trichilia connaroides in hypercholesterolemic rats and, subsequently, to evaluate the possible mechanism of its antihyperlipidemic effect.Materials and Methods:The antihyperlipidemic activity of CETC and METC (100 mg/kg) in hypercholesterolemic rats was investigated by recording the serum lipid profile after a month-long oral treatment of these extracts. Further, hypercholesterolemic regression test and hypercholesterolemic progression test were carried out to understand the possible mechanism of its antihypercholesterolemic effect. The data were analyzed for statistical significance by one-way ANOVA, followed by Dunnet's test.Results and Conclusion:Hypercholesterolemic rats treated with CETC and METC produced a significant fall (P<0.05) in plasma triglyceride, total cholesterol, very low density lipoprotein (VLDL )-cholesterol and low density lipoprotein (LDL)-cholesterol and rise (P < 0.05) in high density lipoprotein (HDL) -cholesterol. A significant reduction (P < 0.01) in atherogenic index, increase (P < 0.05) in body weight and an insignificant influence on food intake were also observed at the end of the study. A hypercholesterolemic regression test revealed a significant reduction (P < 0.05) in the serum cholesterol level in both CETC and METC extract-treated animals. During the hypercholesterolemic progression test, a similar reduction in the serum cholesterol level was observed only in the METC extract-treated animals. The antihyperlipidemic effect was similar to fenofibrate and ezitimibe. Significant changes in the lipid profile in hypercholesterolemic animals confirm a potential antihyperlipidemic activity of the extracts. The CETC and METC extracts influenced the absorption and metabolism of dietary cholesterol to elicit the antihyperlipidemic effect.
机译:目的:这项研究的主要目的是研究高胆固醇血症大鼠的毛顶毛叶中氯仿(CETC)和甲醇(METC)提取物的抗高血脂作用,然后评估其抗高血脂作用的可能机制。方法:通过记录这些提取物经过一个月的口服治疗,通过记录血脂水平,研究高胆固醇血症大鼠的CETC和METC(100 mg / kg)的降血脂活性。此外,进行了高胆固醇血症回归试验和高胆固醇血症进展试验,以了解其抗高胆固醇血症作用的可能机制。结果和结论:CETC和METC治疗的高胆固醇血症大鼠血浆甘油三酸酯,总胆固醇,极低密度脂蛋白(P <0.05)显着下降(P <0.05)。 VLDL-胆固醇和低密度脂蛋白(LDL)-胆固醇和高密度脂蛋白(HDL)-胆固醇升高(P <0.05)。在研究结束时还观察到动脉粥样硬化指数显着降低(P <0.01),体重增加(P <0.05)和对食物摄入量的影响不显着。高胆固醇血症回归测试显示,CETC和METC提取物治疗的动物的血清胆固醇水平显着降低(P <0.05)。在高胆固醇血症进展测试中,仅在经METC提取物治疗的动物中观察到了血清胆固醇水平的类似降低。降血脂作用类似于非诺贝特和依奇替米贝。高胆固醇血症动物脂质分布的显着变化证实了提取物具有潜在的降血脂活性。 CETC和METC提取物影响膳食胆固醇的吸收和代谢,从而引起降血脂作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号